• Kerridge BT, Pickering RP, Saha TD, Ruan WJ, Chou SP, Zhang H, Jung J, Hasin DS (2017) Prevalence, sociodemographic correlates and DSM-5 substance use disorders and other psychiatric disorders among sexual minorities in the United States. Drug Alcohol Depend 170:82–92. https://doi.org/10.1016/j.drugalcdep.2016.10.038

  • Papazisis G, Tzachanis D (2014) Pregabalin’s abuse potential: a mini review focusing on the pharmacological profile. Int J Clin Pharmacol Ther 52(8):709–716. https://doi.org/10.5414/CP202118

    CAS 
    Article 
    PubMed 

    Google Scholar
     

  • Drug Enforcement Administration (2005) Department of Justice schedules of controlled substances: placement of pregabalin into schedule V. Final rule. Fed Regist 70(144):43633


    Google Scholar
     

  • Lancia M, Gambelunghe A, Gili A, Bacci M, Aroni K, Gambelunghe C (2020) Pregabalin abuse in combination with other drugs: monitoring among methadone patients. Front Psychiatry 10:1022

    Article 

    Google Scholar
     

  • Bastiaens L, Galus J, Mazur C (2016) Abuse of gabapentin is associated with opioid addiction. Psychiatr Q 87(4):763–767

    Article 

    Google Scholar
     

  • Gabr AA (2019) Prevalence and risk factors of pregabalin misuse among patients with substance use disorder. Al-Azhar Assiut Med J 17(4):393

    Article 

    Google Scholar
     

  • King MA (2018) Pregabalin and gabapentin associated with depression and suicidal ideation. BMJ 363:k4979

    Article 

    Google Scholar
     

  • Dean A, Sullivan KM, Soe MM (2013) OpenEpi: Open Source Epidemiologic Statistics for Public Health. Version 2.3.1

  • First MB, Spitzer RL, Gibbon M, Williams JB (2002) Structured Clinical Interview for DSM-IV-TR axis I disorders, research version, patient edition. SCID-I/P, New York, pp 94–91


    Google Scholar
     

  • El Missiry A, Sorour A, Sadek A, Fahy TA, Mawgoud M, Asaad T (2003) Homicide and psychiatric illness: an Egyptian study [MD thesis]. Faculty of Medicine, Ain Shams University, Cairo


    Google Scholar
     

  • First M, Gibbon M, Spitzer R (1997) Structured Clinical Interview for DSM-IV axis II personality disorders (SCID-II). American Psychiatric Press; Inc

  • Zimmerman M, Pfohl B, Coryell W, Stangl D, Corenthal C (1988) Diagnosing personality disorder in depressed patients: a comparison of patient and informant interviews. Arch Gen Psychiatry 45:733–737

    CAS 
    Article 

    Google Scholar
     

  • Hatata H, Khalil A, Asaad T (2003) Dual diagnosis in substance use disorders a study in Egyptian sample. Unpublished MD thesis. Institute of psychiatry .Ain shams university, Egypt


    Google Scholar
     

  • Beck AT, Steer RA, Carbin MG (1988) Psychometric properties of the Beck Depression Inventory: twenty-five years of evaluation. Clin Psychol Rev 8(1):77–100

    Article 

    Google Scholar
     

  • Beck, A. T., & Beamesderfer, A. (1974). Assessment of depression: the depression inventory. S. Karger.


    Google Scholar
     

  • Abdel-Khalek AM (1998) Internal consistency of an Arabic adaptation of the Beck Depression Inventory in four Arab countries. Psychol Rep 82(1):264–266

    CAS 
    Article 

    Google Scholar
     

  • Beck AT, Steer RA, Ranieri WF (1988) Scale for suicide ideation: psychometric properties. J Clin Psychol 44:499–505

    CAS 
    Article 

    Google Scholar
     

  • Hamilton M (1959) Hamilton Anxiety Rating Scale. Brit J Med Psychol 32:50–55

    CAS 
    Article 

    Google Scholar
     

  • Maier W, Buller R, Philipp M, Heuser I (1988) The Hamilton anxiety scale: reliability, validity and sensitivity to change in anxiety and depressive disorders. J Affect Disord 14(1):61–68

    CAS 
    Article 

    Google Scholar
     

  • Thompson E (2015) Hamilton rating scale for anxiety (HAM-A). Occup Med 65(7):601

    Article 

    Google Scholar
     

  • Fateem L (1998) Arabic manual of Hamilton anxiety scale translated and adapted by Lotfy Fateem. The Anglo-Egyptian Bookshop, Egypt


    Google Scholar
     

  • IBM (2020) IBM SPSS Statistics for Windows, Version 27. IBM Corp, Armon http://www-01.ibm.com/support/docview.wss?uid=swg27049428


    Google Scholar
     

  • Lai HMX, Cleary M, Sitharthan T, Hunt GE (2015) Prevalence of comorbid substance use, anxiety and mood disorders in epidemiological surveys, 1990–2014: a systematic review and meta-analysis. Drug Alcohol Depend 154:1–13

    Article 

    Google Scholar
     

  • Terracciano A, Löckenhoff CE, Crum RM, Bienvenu OJ, Costa PT (2008) Five-factor model personality profiles of drug users. BMC Psychiatry 8(1):1–10

    Article 

    Google Scholar
     

  • Tandon VR, Mahajan V, Gillani ZH, Mahajan A (2013) Pregabalin-induced self-harm behavior. Indian J Pharmacol 45(6):638

    Article 

    Google Scholar
     

  • Kienast T, Stoffers J, Bermpohl F, Lieb K (2014) Borderline personality disorder and comorbid addiction: epidemiology and treatment. Deutsches Ärzteblatt Int 111(16):280


    Google Scholar
     

  • Evren C, Kural S, Erkiran M (2006) Antisocial personality disorder in Turkish substance dependent patients and its relationship with anxiety, depression and a history of childhood abuse. Israel J Psychiatry Relat Sci 43(1):40


    Google Scholar
     

  • Parmar A, Kaloiya G (2018) Comorbidity of personality disorder among substance use disorder patients: a narrative review. Indian J Psychol Med 40(6):517–527

    Article 

    Google Scholar
     

  • Sayed SM, Ahmad HEK, Sayied NE, El-Aziz A, Mohamed A (2020) Effect of psycho-educational program on depression among drug addict patients at Assiut University Hospital. Assiut Sci Nurs J 8(20):45–55


    Google Scholar
     

  • Mohamed II, Ahmad HEK, Hassaan SH, Hassan SM (2020) Assessment of anxiety and depression among substance use disorder patients: a case-control study. Middle East Curr Psychiatry 27:1–8

    Article 

    Google Scholar
     

  • Singh D, Yadav JS, Jamuda BK, Singh P (2019) Oral pregabalin as premedication on anxiolysis and stress response to laryngoscopy and endotracheal intubation in patients undergoing laparoscopic cholecystectomy: a randomized double-blind study. Anesth Essays Res 13(1):97

    Article 

    Google Scholar
     

  • Fahmy MT, Haggag WL, Mohamed KA, Baalash AA (2015) A study of the personality traits and the level of anxiety in suicidal polydrug users. Egyptian J Psychiatry 36(2):106

    Article 

    Google Scholar
     

  • Rodríguez-Cintas L, Daigre C, Braquehais MD, Palma-Alvarez RF, Grau-López L, Ros-Cucurull E et al (2018) Factors associated with lifetime suicidal ideation and suicide attempts in outpatients with substance use disorders. Psychiatry Res 262:440–445

    Article 

    Google Scholar
     

  • Philips B, Wennberg P, Konradsson P, Franck J (2018) Mentalization-based treatment for concurrent borderline personality disorder and substance use disorder: a randomized controlled feasibility study. Eur Addict Res 24(1):1–8

    Article 

    Google Scholar
     

  • Rights and permissions

    Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.

    Disclaimer:

    This article is autogenerated using RSS feeds and has not been created or edited by OA JF.

    Click here for Source link (https://www.springeropen.com/)